FI940851A - Nya glykosfingolipider och användning av dem - Google Patents

Nya glykosfingolipider och användning av dem Download PDF

Info

Publication number
FI940851A
FI940851A FI940851A FI940851A FI940851A FI 940851 A FI940851 A FI 940851A FI 940851 A FI940851 A FI 940851A FI 940851 A FI940851 A FI 940851A FI 940851 A FI940851 A FI 940851A
Authority
FI
Finland
Prior art keywords
sphingoglycolipid
phenolipids
integer
new glucose
chem
Prior art date
Application number
FI940851A
Other languages
English (en)
Finnish (fi)
Other versions
FI940851A0 (sv
FI105189B (sv
Inventor
Tatsuo Higa
Koji Akimoto
Yasuhiko Koezuka
Teruyuki Sakai
Masahiro Morita
Takenori Natori
Original Assignee
Kirin Brewery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery filed Critical Kirin Brewery
Publication of FI940851A0 publication Critical patent/FI940851A0/sv
Publication of FI940851A publication Critical patent/FI940851A/sv
Application granted granted Critical
Publication of FI105189B publication Critical patent/FI105189B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI940851A 1991-08-29 1994-02-23 Förfarande för framställning av nya glykosfingolipider FI105189B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP24438491 1991-08-29
JP3244384A JPH0559081A (ja) 1991-08-29 1991-08-29 新規スフインゴ糖脂質、その製造法および使用
JP9200561 1992-04-28
PCT/JP1992/000561 WO1993005055A1 (en) 1991-08-29 1992-04-28 Novel sphingoglycolipid and use thereof

Publications (3)

Publication Number Publication Date
FI940851A0 FI940851A0 (sv) 1994-02-23
FI940851A true FI940851A (sv) 1994-02-23
FI105189B FI105189B (sv) 2000-06-30

Family

ID=17117885

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940851A FI105189B (sv) 1991-08-29 1994-02-23 Förfarande för framställning av nya glykosfingolipider

Country Status (19)

Country Link
EP (1) EP0609437B1 (sv)
JP (2) JPH0559081A (sv)
KR (1) KR100220793B1 (sv)
AT (1) ATE181922T1 (sv)
AU (1) AU665536B2 (sv)
CA (1) CA2116442C (sv)
DE (1) DE69229557T2 (sv)
DK (1) DK0609437T3 (sv)
ES (1) ES2134213T3 (sv)
FI (1) FI105189B (sv)
GR (1) GR3030723T3 (sv)
HK (1) HK1009967A1 (sv)
HU (1) HU223839B1 (sv)
NO (1) NO180338C (sv)
PT (1) PT100736B (sv)
SG (1) SG44031A1 (sv)
TW (1) TW197446B (sv)
WO (1) WO1993005055A1 (sv)
ZA (1) ZA923239B (sv)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
TW261533B (sv) * 1992-07-16 1995-11-01 Kirin Brewery
WO1994009020A1 (en) * 1992-10-22 1994-04-28 Kirin Beer Kabushiki Kaisha Novel shingoglycolipid and use thereof
EP0694558B1 (en) * 1993-04-15 1999-01-27 Kirin Beer Kabushiki Kaisha Novel sphingoglycolipid and use thereof
TW555562B (en) 1996-12-27 2003-10-01 Kirin Brewery Method for activation of human antigen-presenting cells, activated human antigen-presenting cells and use thereof
TW575420B (en) * 1997-09-22 2004-02-11 Kirin Brewery Composition for enhancing cellular immunogenicity comprising alpha-glycosylceramides
AU782539B2 (en) * 2000-01-14 2005-08-04 Meiji Dairies Corporation Antigen-specific IgE antibody production inhibitors
JP2002030093A (ja) * 2000-03-13 2002-01-29 Nof Corp グリコシルセラミドの精製方法
CN100439383C (zh) 2001-08-16 2008-12-03 阿斯比奥制药株式会社 糖脂及其作为有效成分的用于自体免疫疾病的药物
BR0314640A (pt) * 2002-09-20 2005-08-02 Kirin Brewery Inibidor de vìrus de hepatite c compreendendo, como um ingrediente ativo, alfa-glicosilceramida
JP4585172B2 (ja) * 2003-01-31 2010-11-24 森永乳業株式会社 骨形成促進剤
HUE037560T2 (hu) * 2003-02-14 2018-09-28 Japan President Nat Ct Neurology & Psychiatry Glikolipid-származékok, eljárás elõállításukra, szintézis-köztitermékeik, és eljárás a köztitermékek elõállítására
JP4753089B2 (ja) * 2004-12-20 2011-08-17 株式会社岡安商店 体内脂肪の分解促進作用を有する組成物及びそれを含有する食品又は食品配合剤
JP2007070311A (ja) * 2005-09-09 2007-03-22 Gunma Univ α−ガラクトシルセラミドからなる感染症予防剤及び感染症治療剤
EP1776963A1 (en) 2005-10-19 2007-04-25 Gbf-Gesellschaft Für Biotechnologische Forschung Mbh Hexosylceramides as adjuvants and their uses in pharmaceutical compositions
WO2008047174A1 (en) * 2006-10-18 2008-04-24 Centre National De La Recherche Scientifique Alpha-galactosylceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them
KR100868959B1 (ko) * 2006-12-30 2008-11-17 재단법인서울대학교산학협력재단 알파-갈락토실세라마이드 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는면역보조용 약학적 조성물
US7959907B2 (en) 2007-02-21 2011-06-14 Vib Vzw Method of treating cancer by combination therapy using TNF and alpha-galactosylceramide
JP4995172B2 (ja) * 2008-10-10 2012-08-08 壽製薬株式会社 糖脂質誘導体、その製造方法並びにそれを有効成分とする医薬
RU2532222C2 (ru) 2009-02-16 2014-10-27 Серенис Терапьютикс Холдинг С.А, Миметики аполипопротеина а-i
JP5095683B2 (ja) * 2009-07-06 2012-12-12 壽製薬株式会社 新規糖脂質誘導体及びこれを有効成分とする製剤
JP5025692B2 (ja) * 2009-07-06 2012-09-12 壽製薬株式会社 糖脂質誘導体の製造方法
JP2010254718A (ja) * 2010-08-13 2010-11-11 Morinaga Milk Ind Co Ltd 骨形成促進剤
NO2629776T3 (sv) 2010-10-18 2018-01-13
WO2012074116A1 (ja) 2010-12-02 2012-06-07 独立行政法人理化学研究所 アロNKT細胞を用いた免疫療法およびそのためのT細胞抗原受容体（TCR）遺伝子のα鎖領域が均一なVα-Jαに再構成されている細胞および該細胞由来NKT細胞のバンキング
WO2014021464A1 (ja) * 2012-08-03 2014-02-06 独立行政法人理化学研究所 水酸化ｋｒｎ７０００類縁体及びその用途
EP2903622A1 (en) 2012-10-03 2015-08-12 INSERM - Institut National de la Santé et de la Recherche Médicale Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
US10151745B2 (en) 2012-11-21 2018-12-11 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods for determining the risk of acute graft versus host disease
WO2017207040A1 (en) 2016-06-01 2017-12-07 Vib Vzw ANTI-CANCER THERAPY USING A LEPTIN ANTAGONIST AND AN iNKT-CELL ACTIVATOR
KR102328367B1 (ko) * 2019-11-05 2021-11-18 한국해양과학기술원 아젤록심 d를 유효성분으로 함유하는 방사선 민감성 증진용 조성물
JPWO2022118913A1 (sv) 2020-12-04 2022-06-09

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6157594A (ja) * 1984-08-30 1986-03-24 Suntory Ltd ガラクトスフインゴ脂質及びその製造法
JP2588729B2 (ja) * 1987-10-05 1997-03-12 塩野義製薬株式会社 スフィンゴシン誘導体
DE3840044A1 (de) * 1988-11-27 1990-06-07 Behringwerke Ag Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung

Also Published As

Publication number Publication date
KR100220793B1 (ko) 1999-10-01
NO940598L (sv) 1994-04-27
WO1993005055A1 (en) 1993-03-18
FI940851A0 (sv) 1994-02-23
SG44031A1 (en) 1997-11-14
DK0609437T3 (da) 2000-01-31
PT100736A (pt) 1993-09-30
CA2116442C (en) 2000-09-05
JP2774194B2 (ja) 1998-07-09
ZA923239B (en) 1993-05-05
TW197446B (sv) 1993-01-01
NO940598D0 (no) 1994-02-22
EP0609437B1 (en) 1999-07-07
ES2134213T3 (es) 1999-10-01
HUT70435A (en) 1995-10-30
DE69229557D1 (de) 1999-08-12
PT100736B (pt) 1999-04-30
JPH0559081A (ja) 1993-03-09
AU1666492A (en) 1993-04-05
AU665536B2 (en) 1996-01-11
CA2116442A1 (en) 1993-03-18
GR3030723T3 (en) 1999-11-30
ATE181922T1 (de) 1999-07-15
DE69229557T2 (de) 1999-11-25
HU9400596D0 (en) 1994-05-30
NO180338B (no) 1996-12-23
EP0609437A1 (en) 1994-08-10
HK1009967A1 (en) 1999-09-17
FI105189B (sv) 2000-06-30
HU223839B1 (hu) 2005-02-28
EP0609437A4 (en) 1994-08-24
NO180338C (no) 1997-04-02

Similar Documents

Publication Publication Date Title
FI940851A0 (sv) Nya glykosfingolipider och användning av dem
HUT52764A (en) Process for producing pyrimidindione derivatives and pharmaceutical compositions containing them as active components
YU86383A (en) Process for obtaining ethanolamine derivatives
CA2043071A1 (en) Heterocyclic compounds
HUT68721A (en) Benzofuran and benzizoxazole derivatives, pharmaceutical composition containing said compounds as active agent and process for preparing them
IE893653L (en) Compositions and compounds
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
EP1468692A3 (en) Use of 2,6-di-alkyl-4-silyl-phenols for treating xanthoma
HUT54372A (en) Process for producing macrolide compounds and pharmaceutical compositions containing them as active components
EG19557A (en) A process for the preparation of pharmaceutical preparation
HUT48259A (en) Herbicide compositions containing new macrolide active components, and process for producing new macrolide compounds and pharmaceutical compositions containing them as active components
EP0410343A3 (en) Use of bisphenol derivatives in treating diabetes mellitus
ES8304532A1 (es) "procedimiento de preparacion de derivados de etanolamina".
DK0485894T3 (da) Fremgangsmåde til fremstilling af semisyntetiske diastereomerrene N-glycidyl-anthracycliner
HUT65417A (en) Process for producing pharmaceutical compositions for rectal administration containing triazole derivatives
AU8292787A (en) Fluorine-containing macrolide compounds and their use
JPS56122372A (en) Prostaglandin i2 derivative

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: KIRIN PHARMA KABUSHIKI KAISHA

Free format text: KIRIN PHARMA KABUSHIKI KAISHA

PC Transfer of assignment of patent

Owner name: KYOWA HAKKO KIRIN CO., LTD.

Free format text: KYOWA HAKKO KIRIN CO., LTD.

MA Patent expired